Cure Ventures
Cure Ventures is a Boston-based venture capital firm established in 2020, specializing in investments in the life sciences and medical technologies sectors. The firm focuses on seed-stage investments in biotechnology, pharmaceuticals, medical devices, and medtech companies that demonstrate exceptional growth potential and are dedicated to addressing unmet medical needs. By discovering and enabling innovative firms, Cure Ventures aims to accelerate the development and market introduction of novel cures, ultimately benefiting global patient populations. As a Registered Investment Adviser, the firm prioritizes strategic partnerships that align with its mission to enhance healthcare outcomes through cutting-edge solutions.
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Clasp Therapeutics
Series A in 2024
Clasp Therapeutics is a biotechnology company focused on developing innovative cancer immunotherapeutics. The company has created a platform that aims to enhance the ability of the immune system to recognize and eliminate challenging tumors associated with common driver mutations, irrespective of tumor type. By leveraging precision medicine, Clasp Therapeutics seeks to identify cancer-specific markers that allow for the targeted destruction of tumor cells, thereby improving treatment outcomes for patients with difficult-to-treat cancers.
Kenai Therapeutics
Series A in 2024
Kenai Therapeutics is a biotechnology company dedicated to developing therapies for neurodegenerative movement disorders. The company specializes in providing off-the-shelf neuron replacement medicines that serve as effective disease-modifying treatments for various neurological conditions. By focusing on innovative approaches, Kenai Therapeutics aims to equip physicians with advanced techniques for treating disorders such as Parkinson's disease, ultimately enhancing patient care and outcomes in the field of neurology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.